首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Biochemical Pharmacology

Biochemical Pharmacology杂志,由Elsevier Inc.出版,于1958年创刊,Semimonthly,出版语言English,ISSN:0006-2952,E-ISSN:1873-2968。

投稿咨询
Biochemical Pharmacology
Biochemical Pharmacology
Biochemical Pharmacology
SCI SCIE

杂志介绍

JCR分区
Q1
中科院分区
2区
影响因子
6.5
CiteScore
9.3
期刊收录
SCI、SCIE

Biochemical Pharmacology(中文译名:《生化药理学》),ISSN:0006-2952,EISSN:1873-2968,是Elsevier Inc.出版的国际性学术期刊,创刊于1958年,以Semimonthly形式稳定发行,2026年总发文量约736篇。该刊采用非OA开放访问,学科归属为医学 - 药学。该刊是医学、药学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达6.5,2025年期刊CiteScore为9.3,2025年期刊自引率约1.5%,在中科院期刊分区体系中位列医学大类2区TOP 期刊,在所属学科领域具备高学术影响力与国际认可度。Biochemical Pharmacology长期聚焦医学、药学及相关产业的技术应用前沿,平均审稿周期约1.0个月,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、药学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USACHINA MAINLAND、Italy、Spain、GERMANY (FED REP GER)、Japan、South Korea等为核心发文国家与地区;INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)UNIVERSITY OF CALIFORNIA SYSTEM、UNIVERSITY OF BARCELONA、CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)、CIBER - CENTRO DE INVESTIGACION BIOMEDICA EN RED、INSTITUTO DE SALUD CARLOS III、UNIVERSITY OF TEXAS SYSTEM等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
PHARMACOLOGY & PHARMACY 药学
2区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
PHARMACOLOGY & PHARMACY 药学
2区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
PHARMACOLOGY & PHARMACY 药学
2区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q1 41 / 356

88.6

学科:PHARMACOLOGY & PHARMACY SCIE Q1 50 / 356

86.1

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q1 33 / 352

90.8

学科:PHARMACOLOGY & PHARMACY SCIE Q1 47 / 353

86.83


中国学者近期发文

1
Novel targeted therapies and immunological strategies for breast cancer treatmen

Author:Mussa, Ali; Hamid, Mahasin; Talib, Mustafa; Ehinnou, Iletou; Bragoli, Anthony; Hajissa, Khalid; Mokhtar, Noor Fatmawati; Mohamud, Rohimah; Al-Hatamleh, Mohammad A.I.; Hassan, Rosline

Journal: BIOCHEMICAL PHARMACOLOGY. 2026; Vol. 250, Issue , pp. -. DOI: 10.1016/j.bcp.2026.117929

2
SGLT2i-Triggered hyperglycosuria Unveils CDKN2A-Driven distal tubular senescence and EMT, Fueling renal fibrosi

Author:Chen, Yan; Zheng, Sheng-chun; Bai, Yun-feng; Deng, Wei-zhu; Gong, Na; Fu, Yi-fei; Zhang, Zi-yue; Chen, Xiang-mei; Hong, Quan; Sun, Xue-feng

Journal: BIOCHEMICAL PHARMACOLOGY. 2026; Vol. 250, Issue , pp. -. DOI: 10.1016/j.bcp.2026.117942

3
Genistein combined with aerobic exercise protects against alcoholic liver injury through PI3K/AKT/GSK3β signalin

Author:Wang, Haoyu; Zhang, Jun; Li, Yi; Chen, Yuxiu; Yan, Nan; Luo, Zhonghua; Liu, Yunen

Journal: BIOCHEMICAL PHARMACOLOGY. 2026; Vol. 250, Issue , pp. -. DOI: 10.1016/j.bcp.2026.117938

4
Fangchinoline derivative LYY-34 suppresses TNBC by inhibiting BLM DNA helicase from unfolding of c-MYC promoter G-quadruplex DN

Author:Liu, Xiaohua; Zhang, Wenfang; Zhang, Wangming; Lan, Junjie; Song, Shan-Shan; Yang, Long; Pan, Weidong; Liu, Yixin; Xiao, Chao-Da; Liu, Jielin

Journal: BIOCHEMICAL PHARMACOLOGY. 2026; Vol. 250, Issue , pp. -. DOI: 10.1016/j.bcp.2026.117945

5
Pharmacological inhibition of the MST2/Hippo signaling pathway mitigates Toxoplasma gondii-induced apoptosis and immunopathology in macrophage and mice live

Author:Xu, Kangzhi; Zheng, Qiangqiang; Zu, Mingyue; Ma, Jing; Xia, Wentai; Liu, Dandan; Wang, Yanhong; Zhang, Xinjun; Huang, Siyang; Xu, Jinjun; Yang, Jin; Cheng, Darong; Pan, Zhiming; Tao, Jianping; Hou, Zhaofeng

Journal: BIOCHEMICAL PHARMACOLOGY. 2026; Vol. 250, Issue , pp. -. DOI: 10.1016/j.bcp.2026.117944

6
RNF144B deficiency aggravated neuroinflammatory response induced by cerebral ischemic stroke via regulating TRAF3 ubiquitinatio

Author:Hu, Dianbo; Zhao, Shuhui; Jin, Yueting; Yang, Chen; Hu, Yugang; Liu, Qian; Ma, Renzheng

Journal: BIOCHEMICAL PHARMACOLOGY. 2026; Vol. 250, Issue , pp. -. DOI: 10.1016/j.bcp.2026.117936

7
PRDX6 attenuates osteoporotic bone loss by restraining oxidative stress-associated osteoblast senescenc

Author:Chen, Yu; Shen, Xing; Shi, Jia-wei; Zeng, Guan-hai; Zhu, Si-Yuan; Dai, Xiang-heng; Liu, Zhong-yuan; Wang, Yi-qing; Chen, Jian-ting; Liao, Cong-rui

Journal: BIOCHEMICAL PHARMACOLOGY. 2026; Vol. 250, Issue , pp. -. DOI: 10.1016/j.bcp.2026.117947

8
Acetylation in autoimmune diseases: From mechanistic insights to therapeutic prospect

Author:Wen, Junfeng; Zhang, Yihan; Lu, Yao; Chen, Xuling; Zhu, Lei; Zhang, Genxian; Tang, Jialing; Li, He; Su, Wenru

Journal: BIOCHEMICAL PHARMACOLOGY. 2026; Vol. 250, Issue , pp. -. DOI: 10.1016/j.bcp.2026.117958

9
RGS2 facilitates trophoblast function through a loop with the Hippo pathway and ubiquitination of CTG

Author:Zhu, Chongying; Xu, Qiang; An, Zihao; Zhu, Bingquan; Jin, Meiyaun; Tang, Chao

Journal: BIOCHEMICAL PHARMACOLOGY. 2026; Vol. 250, Issue , pp. -. DOI: 10.1016/j.bcp.2026.117955

10
Crosstalk between cytokines and tryptophan metabolism: Therapeutic potential for immune effector cell-associated neurotoxicity syndrom

Author:Wu, Jianghua; Li, Dehu; Mei, Heng; Hu, Yu

Journal: BIOCHEMICAL PHARMACOLOGY. 2026; Vol. 250, Issue , pp. -. DOI: 10.1016/j.bcp.2026.117949


在线咨询

Biochemical Pharmacology

国际简称:BIOCHEM PHARMACOL参考译名:生化药理学

年发文量:736 CiteScore:9.3 是否预警:否 Gold OA文章占比:22.66% 研究类文章占比:77.58%

杂志社联系方式:PERGAMON-ELSEVIER SCIENCE LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND, OX5 1GB

Biochemical Pharmacology